Coya Therapeutics, Inc. (COYA) Tops Q3 EPS by 46c

Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q3 EPS of ($0.13), $0.46 better than the analyst estimate of ($0.59). Revenue for the quarter came in at $3.56 million, versus $0 reported last year.

For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.

You May Also Be Interested In

• Boeing wins $20B U.S. Navy contract for sixth-generation fighter jet
• Anthropic got 47% of its sales from distributors Amazon and Google in 2025 - Reuters
• Boeing receives multiple U.S. defense contracts totaling over $95M